{"task_id": "584cc6c8ed9ac518", "source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 457/905)", "text": " cognition.\nStorms on the sea of neurotransmission\n\n--- Page 463 ---\n449\nNeurology\nTable 10.1 Major neurotransmitters and associated drugs\nDrugs increasing activity (\u2248 agonists) Drugs decreasing activity (\u2248 antagonists)\nDopamine Acts on receptors D1\u20135; aff ects mood and reward-seeking behaviour.\nPramipexole, ropinirole, levodopa, \napomorphine (Parkinson\u2019s*)\nCabergoline (hyperprolactin aemia; \nacromegaly). \nChlorpromazine (schizophrenia, OHCS p340)\nMetoclopramide (nausea)\nInhibition of dopamine signalling may lead to \ndrug induced parkinsonism.\nSerotonin (5-hydroxytryptamine; 5HT) Many receptor types 5HT1\u20137; multiple eff ects.\nLithium (mood stabilizer)\nSumatriptan (migraine)\nBuspirone (partial agonist; anxiety)\nFluoxetine, sertraline (reuptake inhibi-\ntors; depression). \nOndansetron (nausea)\nMirtazapine (depression)\nOlanzapine, clozapine (schizophrenia)\nAmino acids Glutamate and aspartate act as excitatory transmitters on NMDA and \nnon-NMDA receptors\u2014relevant in epilepsy and CNS ischaemia. \ue034-amino butyric acid (GABA) \nis mostly inhibitory.\nGabapentin, valproate (GABA agonists; \nepilepsy and neuropathic pain)\nBenzodiazepines (GABA agonists; seda-\ntion)\nBaclofen (GABA agonists; spasticity)\nAlcohol (GABA agonist)\u2020\nMemantine (glutamate antagonist; \ndementia)\nAcetylcholine Multiple receptors classed into muscarinic and nicotinic types. Peripher-\nal agonists used in glaucoma (pilocarpine); myasthenia (anticholinesterases). Peripheral \nantagonists used in asthma (ipratropium); incont inence; to dry secretions pre-op; to \ndilate pupils; to \ue000 heart rate (atropine). Centrally acting drugs include:\nDonepezil, galantamine, rivastigmine \n(acetylcholinesterase inhibitors; \ndementia)\nProcyclidine, trihexyphenidyl (drug-induced \nparkinsonism)\nHistamine and purines (eg ATP)\nCyclizine (antihistamine; nausea)\nPurinergic receptor blockers (emerging role in \nchronic pain).\nNeuropeptides Multiple and growing list; includes opioids and substance P\nExogenous opioids (wide-ranging anal-\ngesic and mood-related eff ects).\nAprepitant (\ue001chemotherapy-related nausea \nby blocking substance P receptors).\nNoradrenaline, adrenaline (=norepinephrine, epinephrine) 4 rec eptor types: \ue0251\u20132, \ue0201\u20132. \nNoradrenaline is more speci\ufb01 c for \ue025-receptors but both transmitters aff ect all receptors. \nIn the periphery, \ue025-receptors drive arteriolar vasoconstriction and pupillary dilation; \ue0201 \nstimulation leads to \ue000 pulse and myocardial contractility; \ue0202 stimulation leads to bronchodi-\nlatation, uterine relaxation, and arteriolar vasodilation. Centrally acting drugs include:\nClonidine (refractory hypertension)\nTricyclic antidepressants and venlafax-\nine (5HT and noradrenaline reuptake \ninhibitors; depression)\nMAOIs\n*Agonism at D3 receptor agonists may cause pathological behavioural patterns, eg hypersexuality, patho-\nlogical gambling or hobbying, and disorders of impulse control in people having no history of these.\n\u2020In chronic alcohol use, GABA receptors are downregulated; acamprosate, used in alcoholism, may help to \nmaintain GABA signalling after alcohol withdrawal.", "text_length": 3070, "metadata": {"source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 457/905)", "type": "chunk", "chunk_index": 456, "total_chunks": 905, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T17:59:52.955936", "document_uuid": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f", "filename": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf", "category": "medical_pdf", "section": "body", "year": 2017, "outdated": false, "document_id": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f"}, "created_at": "2025-12-11T17:59:52.956883", "status": "complete", "chunks_added": 2}